114 related articles for article (PubMed ID: 11857083)
1. A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining.
Baldeyron C; Jacquemin E; Smith J; Jacquemont C; De Oliveira I; Gad S; Feunteun J; Stoppa-Lyonnet D; Papadopoulo D
Oncogene; 2002 Feb; 21(9):1401-10. PubMed ID: 11857083
[TBL] [Abstract][Full Text] [Related]
2. Fidelity of DNA double-strand break repair in heterozygous cell lines harbouring BRCA1 missense mutations.
Coupier I; Baldeyron C; Rousseau A; Mosseri V; Pages-Berhouet S; Caux-Moncoutier V; Papadopoulo D; Stoppa-Lyonnet D
Oncogene; 2004 Jan; 23(4):914-9. PubMed ID: 14647443
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.
Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY
Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476
[TBL] [Abstract][Full Text] [Related]
4. Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines.
Mérel P; Prieur A; Pfeiffer P; Delattre O
Oncogene; 2002 Aug; 21(36):5654-9. PubMed ID: 12165865
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage.
Nieuwenhuis B; Van Assen-Bolt AJ; Van Waarde-Verhagen MA; Sijmons RH; Van der Hout AH; Bauch T; Streffer C; Kampinga HH
Int J Radiat Biol; 2002 Apr; 78(4):285-95. PubMed ID: 12020440
[TBL] [Abstract][Full Text] [Related]
6. Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair.
Arnold K; Kim MK; Frerk K; Edler L; Savelyeva L; Schmezer P; Wiedemeyer R
Cancer Lett; 2006 Nov; 243(1):90-100. PubMed ID: 16448746
[TBL] [Abstract][Full Text] [Related]
7. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts.
Zhong Q; Boyer TG; Chen PL; Lee WH
Cancer Res; 2002 Jul; 62(14):3966-70. PubMed ID: 12124328
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 requirement for the fidelity of plasmid DNA double-strand break repair in cultured breast epithelial cells.
Thompson EG; Fares H; Dixon K
Environ Mol Mutagen; 2012 Jan; 53(1):32-43. PubMed ID: 22170030
[TBL] [Abstract][Full Text] [Related]
9. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
Slebos RJ; Taylor JA
Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis.
Trenz K; Schütz P; Speit G
Mutagenesis; 2005 Mar; 20(2):131-7. PubMed ID: 15784691
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations.
Ginolhac SM; Gad S; Corbex M; Bressac-De-Paillerets B; Chompret A; Bignon YJ; Peyrat JP; Fournier J; Lasset C; Giraud S; Muller D; Fricker JP; Hardouin A; Berthet P; Maugard C; Nogues C; Lidereau R; Longy M; Olschwang S; Toulas C; Guimbaud R; Yannoukakos D; Szabo C; Durocher F; Moisan AM; Simard J; Mazoyer S; Lynch HT; Goldgar D; Stoppa-Lyonnet D; Lenoir GM; Sinilnikova OM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):90-5. PubMed ID: 12582017
[TBL] [Abstract][Full Text] [Related]
12. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
Zhang J; Powell SN
Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
[TBL] [Abstract][Full Text] [Related]
13. Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.
Moynahan ME; Cui TY; Jasin M
Cancer Res; 2001 Jun; 61(12):4842-50. PubMed ID: 11406561
[TBL] [Abstract][Full Text] [Related]
14. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
Zhuang J; Zhang J; Willers H; Wang H; Chung JH; van Gent DC; Hallahan DE; Powell SN; Xia F
Cancer Res; 2006 Feb; 66(3):1401-8. PubMed ID: 16452195
[TBL] [Abstract][Full Text] [Related]
15. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.
de Campos-Nebel M; Larripa I; González-Cid M
Mutat Res; 2008 Nov; 646(1-2):8-16. PubMed ID: 18812179
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of non-homologous end joining DNA repair in a resistant subset of human chronic lymphocytic leukaemia B cells.
Deriano L; Merle-Béral H; Guipaud O; Sabatier L; Delic J
Br J Haematol; 2006 Jun; 133(5):520-5. PubMed ID: 16681639
[TBL] [Abstract][Full Text] [Related]
18. Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines.
Jacob S; Miquel C; Sarasin A; Praz F
Nucleic Acids Res; 2005; 33(1):106-13. PubMed ID: 15642697
[TBL] [Abstract][Full Text] [Related]
19. Distinctive differences in DNA double-strand break repair between normal urothelial and urothelial carcinoma cells.
Windhofer F; Krause S; Hader C; Schulz WA; Florl AR
Mutat Res; 2008 Feb; 638(1-2):56-65. PubMed ID: 17928011
[TBL] [Abstract][Full Text] [Related]
20. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.
Bell DW; Erban J; Sgroi DC; Haber DA
Cancer Res; 2002 May; 62(10):2741-3. PubMed ID: 12019146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
